ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.19
+0.04 (0.49%)
May 14, 2026, 11:03 AM EDT - Market open
ImmunityBio Market Cap
ImmunityBio has a market cap or net worth of $8.58 billion as of May 14, 2026. Its market cap has increased by 290.37% in one year.
Market Cap
8.58B
Enterprise Value
9.15B
1-Year Change
290.37%
Ranking
Category
Stock Price
$8.19
Market Cap Chart
Since March 10, 2021, ImmunityBio's market cap has decreased from $14.82B to $8.58B, a decrease of -42.13%. That is a compound annual growth rate of -10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 8.54B | 337.69% |
| Dec 31, 2025 | 1.95B | 4.33% |
| Dec 31, 2024 | 1.87B | -44.23% |
| Dec 29, 2023 | 3.35B | 61.49% |
| Dec 30, 2022 | 2.08B | -14.18% |
| Dec 31, 2021 | 2.42B | -83.68% |
| Mar 10, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.16B |
| ABIVAX Société Anonyme | 9.71B |
| Cytokinetics | 9.28B |
| Praxis Precision Medicines | 9.25B |
| Krystal Biotech | 9.22B |
| Nuvalent | 8.25B |
| Halozyme Therapeutics | 7.87B |
| Vaxcyte | 7.80B |